4.6 Article

Azogabazine; a photochromic antagonist of the GABA(A) receptor

Journal

ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 14, Issue 28, Pages 6676-6678

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ob01101b

Keywords

-

Funding

  1. BBSRC
  2. Pfizer
  3. EPSRC UK National Mass Spectrometry Facility (NMSF, Swansea)
  4. MRC
  5. Leverhulme Trust
  6. MRC [MR/K005537/1] Funding Source: UKRI
  7. Biotechnology and Biological Sciences Research Council [1089376] Funding Source: researchfish
  8. Medical Research Council [MR/K005537/1] Funding Source: researchfish

Ask authors/readers for more resources

The design and synthesis of azogabazine is described, which represents a highly potent (IC50 = 23 nM) photoswitchable antagonist of the GABA(A) receptor. An azologization strategy is adopted, in which a benzyl phenyl ether in a high affinity gabazine analogue is replaced by an azobenzene, with resultant retention of antagonist potency. We show that cycling from blue to UV light, switching between trans and cis isomeric forms, leads to photochemically controlled antagonism of the GABA ion channel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available